The randomized clinical trial: bias in analysis.
暂无分享,去创建一个
[1] Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. , 1978, The New England journal of medicine.
[2] D. Sackett,et al. Controversy in counting and attributing events in clinical trials. , 1979, The New England journal of medicine.
[3] Anna C. Balazs,et al. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. , 1980, The New England journal of medicine.
[4] Q E Whiting-O'Keefe,et al. Controlled clinical trials. , 1983, The American journal of medicine.
[5] Max Halperin,et al. Sample sizes for medical trials with special reference to long-term therapy , 1968 .
[6] K Uberla,et al. Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo , 1979, Thrombosis and Haemostasis.
[7] J. Ware,et al. Randomized clinical trials. Perspectives on some recent ideas. , 1976, The New England journal of medicine.
[8] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[9] T C Chalmers,et al. ETHICS IN COOPERATIVE CLINICAL TRIALS , 1970, Annals of the New York Academy of Sciences.
[10] K. Uberla,et al. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. , 1980, Haemostasis.
[11] Proceedings of the Workshop on platelet-active drugs in the secondary prevention of cardiovascular events. February 20-21, 1980, National Institutes of Health, Bethesda, Maryland. , 1980, Circulation.
[12] M. Schork,et al. The determination of sample size in treatment-control comparisons for chronic disease studies in which drop-out or non-adherence is a problem. , 1967, Journal of chronic diseases.
[13] G. Kolata. FDA says no to anturane. , 1980, Science.
[14] J. Hampton,et al. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. , 1980, British medical journal.
[15] J. Wittes,et al. Analysis of data from clinical trials. , 1983, Annals of internal medicine.
[16] D. DeMets,et al. Sample sizes for long-term medical trial with time-dependent dropout and event rates. , 1980, Controlled clinical trials.